Schedule 13G ownership disclosure
N/A
Common stock, par value $0.001 per share · CUSIP: 282559103
Event date: 2024-12-19
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Deep Track Capital, LP
Shares: 6,477,949.00 · Class: 5.41%
- Deep Track Biotechnology Master Fund, Ltd.
Shares: 6,477,949.00 · Class: 5.41%
- David Kroin
Shares: 6,477,949.00 · Class: 5.41%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-24-005416
- Form type
- SCHEDULE 13G
- Filer
- 89bio, Inc.
- CIK
- CIK 1785173
- Filed
- Dec 23, 2024
- Reporting period
- Dec 19, 2024
- Description
- Schedule 13G beneficial ownership